Combination therapy for selected sex steroid dependent cancers
US4760053A · kind A · utility
58Cited by
19References
13Claims
0Family size
Inventor
Key dates
| Filing date | Jul 31, 1986 |
| Grant date | Jul 26, 1988 |
| Priority date | — |
| Expiry date | Jul 31, 2006 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A combination therapy for treatment of selected sex steroid dependent cancers in susceptible warm-blooded animals comprising administering to such animals whose hormone output of their testes or ovaries, respectively, is blocked a therapeutically effective amount of an antiandrogen and/or an antiestrogen and/or at least one inhibitor of sex steroid biosynthesis or pharmaceutical compositions thereof wherein the selected sex steroid dependent cancer are, for example, testicular cancer, ovarian cancer, renal cancer or uterine cancer is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.